Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Spinal Cord Stimulation Combined With Brain-Computer Interface Rehabilitation to Improve Motor Function After Stroke (SCS-BCI Rehab)

10 novembre 2026 aggiornato da: Qingdao Central Hospital

A Study on the Efficacy Evaluation of Spinal Cord Stimulation Combined With a Brain-Computer Interface for Improving Motor Function in Patients With Post-Stroke Hemiplegia Based on Multi-Source Neurophysiological Data

This study evaluates the effects of spinal cord stimulation (SCS) combined with brain-computer interface (BCI)-assisted rehabilitation on motor function in patients with post-stroke hemiplegia using multisource neurophysiological data. In this single-group study with repeated measurements, participants undergo four weeks of SCS combined with BCI-driven upper- and lower-limb rehabilitation. Immediate motor performance is compared between SCS ON and OFF conditions under standardized tasks. Changes in motor function and multisource neurophysiological and kinematic measures are also assessed before and after rehabilitation to characterize treatment responses and explore their relationships with clinical motor improvement.

Panoramica dello studio

Descrizione dettagliata

This is a single-group study using a within-participant pre-post design with repeated measurements. The study enrolls patients with post-stroke hemiplegia who meet the clinical indications for spinal cord stimulation (SCS) surgery and require SCS treatment. Following preoperative baseline assessment, participants undergo SCS implantation based on clinical indications, followed by stimulation parameter adjustment, individualized brain-computer interface (BCI) model calibration, and rehabilitation device setup.

The study includes four weeks of SCS combined with BCI-assisted synchronized upper- and lower-limb active rehabilitation. The first week includes postoperative recovery, stimulation parameter adjustment, and early closed-loop training. During rehabilitation, the BCI system identifies motor intentions from electroencephalography (EEG) signals in real time and drives upper- and lower-limb rehabilitation robots to provide corresponding assisted movements, establishing a closed-loop process integrating motor intention, robotic assistance, and sensorimotor feedback. Training is planned for three to five sessions per week, with 45-60 minutes of effective training per session.

Repeated measurements under SCS ON and OFF conditions are performed to evaluate the immediate effects of stimulation. With BCI closed-loop tasks, robotic assistance settings, and movement requirements held constant, motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS OFF and ON conditions. At least one standardized ON/OFF comparison is conducted each week during the intervention period.

Assessments are conducted at the preoperative baseline (T0), postoperative immediate-effect assessment (T1), week-2 mid-intervention assessment (T2), week-4 endpoint assessment (T3), and follow-up (T4). Clinical motor function assessments and multisource data, including EEG, functional near-infrared spectroscopy, electromyography, electrodermal activity, upper- and lower-limb kinematics, and BCI control logs, are used to evaluate changes in motor function, cortical activity, muscle activation patterns, interlimb coordination, and BCI closed-loop performance. Relationships between objective measures and improvements in clinical motor function are also examined.

Tipo di studio

Osservativo

Iscrizione (Stimato)

40

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Shandong
      • Qingdao, Shandong, Cina, 266033
        • Reclutamento
        • Qingdao Central Hospital, University of Health and Rehabilitation Sciences
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 75 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population consists of adults aged 18 to 75 years with imaging-confirmed ischemic or hemorrhagic stroke and unilateral hemiplegia. Participants must meet the clinical indications for spinal cord stimulation (SCS) implantation and be scheduled to undergo SCS surgery for clinical reasons. They must be clinically stable and able to complete brain-computer interface (BCI) calibration, synchronized upper- and lower-limb rehabilitation assessments, and multisource physiological data collection

Descrizione

Inclusion Criteria

  1. Age 18-75 years.
  2. Patients who meet the clinical indications for SCS surgery, require SCS to improve their condition, and plan to undergo the procedure at the study center.
  3. Ischemic or hemorrhagic stroke confirmed by CT or MRI.
  4. Unilateral hemiplegia with assessable motor dysfunction in both the affected upper and lower limbs.
  5. Stable clinical condition and ability to cooperate with SCS implantation surgery, BCI calibration, synchronized upper- and lower-limb robotic rehabilitation, and collection of all multisource physiological data.
  6. Adequate cognitive and comprehension abilities to complete motor imagery or motor-attempt tasks and meet the requirements for BCI modeling and closed-loop control.
  7. Meets the clinical indications for epidural SCS implantation based on neurosurgical evaluation.
  8. Body size, joint range of motion, and tolerance of sitting or standing are compatible with the safe use of upper- and lower-limb rehabilitation robots.
  9. Written informed consent signed by the patient or their legally authorized representative.

Exclusion Criteria

  1. Severe cognitive impairment, complete aphasia, or severe unilateral spatial neglect that prevents completion of all study tasks.
  2. Uncontrolled epilepsy or frequent seizures during the previous three months.
  3. Contraindications to surgery or anesthesia, including severe cardiopulmonary disease, coagulation disorders, or active systemic infection.
  4. Implanted electronic medical devices with electromagnetic compatibility conflicts involving the SCS system, EEG/fNIRS brain recording devices, or rehabilitation robots.
  5. Severe limb contracture, persistent severe pain, structural joint injury, or positional intolerance that prevents standardized synchronized rehabilitation training.
  6. Skin lesions or skin disorders on the head or limbs that prevent the use of EEG, fNIRS, EMG, or electrodermal sensors.
  7. Any other condition judged by the investigator to make participation in the study inappropriate.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
SCS Combined With BCI-Assisted Synchronized Upper- and Lower-Limb Active Rehabilitation

All participants receive SCS combined with EEG-driven BCI-assisted synchronized upper- and lower-limb active rehabilitation. After baseline assessment, SCS implantation, and parameter adjustment, participants complete four weeks of training and weekly SCS ON/OFF comparisons under consistent BCI tasks and robotic assistance settings. Clinical motor outcomes, multisource neurophysiological signals, kinematics, and BCI control logs are collected

An epidural SCS system is used, comprising stimulation electrodes, a pulse generator or external stimulator, a programming system, and an event recording system. The clinical team determines the stimulation target according to motor impairments, surgical safety, and the established treatment plan. Standardized SCS OFF and ON comparisons are performed under consistent BCI tasks and robotic assistance settings, with stimulation parameters, motor performance, and related physiological data recorded

The BCI active rehabilitation system identifies motor intention during imagery or attempted movement from real-time EEG signals and triggers corresponding assisted movements using upper- and lower-limb rehabilitation robots, forming a closed loop between motor intention, sensory feedback, and limb movement. Rehabilitation continues for four weeks, three to five times per week (preferably five), with 45-60 minutes of effective training per session. At least one standardized SCS ON/OFF comparison is performed weekly

Altri nomi:
  • EEG-Driven BCI-Assisted Synchronized Upper- and Lower-Limb Active Rehabilitation

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Difference in Immediate Motor Task Performance Between SCS ON and OFF Conditions
Lasso di tempo: Intervention weeks 1-4 (T1-T3)

Motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS ON and OFF conditions, with BCI closed-loop mode and robotic assistance parameters kept consistent, to evaluate the immediate effects of SCS

Intervention weeks 1-4 (T1-T3)
Change in Upper- and Lower-Extremity Fugl-Meyer Assessment Scores
Lasso di tempo: Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

The Fugl-Meyer Assessment (FMA) is used to evaluate changes in upper- and lower-extremity motor function separately before and after four weeks of combined rehabilitation

Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)
Pearson/Spearman Correlation Between Multisource Objective Measures and Clinical Motor Improvement
Lasso di tempo: Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

Pearson or Spearman correlation analysis will be performed to examine the correlation between multisource neurophysiological measures (EEG, fNIRS, EMG, electrodermal), kinematic parameters, and BCI closed-loop performance metrics, and the change in Fugl-Meyer Assessment (FMA) score, to identify objective features linked to the effects of combined rehabilitation.

Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in 10-Meter Walk Test Speed
Lasso di tempo: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

Walking ability is assessed using the 10-Meter Walk Test.

T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
Change in Modified Ashworth Scale Scores
Lasso di tempo: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

Changes in spasticity of the affected upper and lower limbs are assessed using the Modified Ashworth Scale

T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
Changes in Motor-Related EEG Features
Lasso di tempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in movement-related EEG rhythms, movement-related cortical potentials, and motor intention decoding features are assessed

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
Changes in Motor-Area fNIRS Hemodynamic Responses
Lasso di tempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in motor-area hemodynamic responses during motor tasks are assessed using functional near-infrared spectroscopy (fNIRS)

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
Changes in Upper- and Lower-Limb EMG Activity and Muscle Synergies
Lasso di tempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in target-muscle activation, active contribution, abnormal muscle synergies, co-contraction, and interlimb temporal coupling are assessed using upper- and lower-limb electromyography (EMG)

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
Changes in Electrodermal Responses and Stimulation Tolerability
Lasso di tempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), including assessments during the 4-week intervention period

Electrodermal responses and stimulation tolerability are evaluated using electrodermal signals and records of stimulation-related discomfort

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), including assessments during the 4-week intervention period
Changes in Upper- and Lower-Limb Kinematics and Coordination
Lasso di tempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in movement speed, smoothness, trajectory deviation, joint range of motion, gait or pedaling symmetry, and interlimb coordination are assessed

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
BCI Decoding and Closed-Loop Control Performance
Lasso di tempo: From initial BCI calibration (T0, 1-2 weeks before surgery) to end of intervention week 4 (T3), with follow-up assessment at T4 (4 weeks after SCS electrode removal)

BCI performance is evaluated using decoding accuracy, valid trigger rate, false trigger rate, control latency, robotic task completion rate, assistance level, and online model stability

From initial BCI calibration (T0, 1-2 weeks before surgery) to end of intervention week 4 (T3), with follow-up assessment at T4 (4 weeks after SCS electrode removal)
Safety, Training Completion, and Data Acquisition Quality
Lasso di tempo: During the 4-week intervention after SCS implantation, with final assessment at T4 (4 weeks after SCS electrode removal)

SCS-, BCI-, and robotic device-related adverse events, training completion, device tolerability, and the completeness and quality of synchronized upper- and lower-limb data acquisition are recorded

During the 4-week intervention after SCS implantation, with final assessment at T4 (4 weeks after SCS electrode removal)
Change in Berg Balance Scale Score
Lasso di tempo: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

Balance function is assessed using the Berg Balance Scale.

T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Collaboratori

Investigatori

  • Investigatore principale: Feng Jin, MD, Qingdao Central Hospital, University of Health and Rehabilitation Sciences

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

21 ottobre 2026

Completamento primario (Stimato)

30 settembre 2027

Completamento dello studio (Stimato)

31 marzo 2028

Date di iscrizione allo studio

Primo inviato

22 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 novembre 2026

Primo Inserito (Effettivo)

17 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared with external researchers. Study data will be used for analyses within this research project. Study findings will be reported in aggregate form while protecting participant privacy

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi